Regulatory Filings • Sep 16, 2024
Regulatory Filings
Open in ViewerOpens in native device viewer
Roblon A/S Fabriksvej 7, Gærum DK-9900 Frederikshavn Denmark +45 9620 3300
For some time, and particularly in the US market, Roblon has been adversely affected by market conditions in the FOC industry. Roblon's US subsidiary has been exposed to growing competition over the course of 2024, especially from overseas competitors in India and China.
Despite substantial investments in increasing production capacity and productivity-enhancing initiatives in Roblon's US subsidiary, Management finds no basis for continuing activities in the US FOC market. Consequently, the Roblon Group, in collaboration with selected advisory business partners, has commenced a process to divest the US subsidiary.
As yet, Management is not able to determine how a divestment would affect the financial statements.
Management will share information about the divestment process in due course.
Management maintains the previously announced full-year guidance for 2023/24 of revenue of around DKKm 370, an operating profit before depreciation, amortisation and impairment and before special items (EBITDA) of around DKKm 25 and an operating profit before special items (EBIT) of around DKKm 0.
Distribution of guided figures:
| DKKm | Continuing operations | Discontinued operations |
Total |
|---|---|---|---|
| Revenue | ~ 250 | ~ 120 | ~ 370 |
| EBITDA before special items | ~ 40 | ~ -15 | ~ 25 |
| EBIT before special items | ~ 24 | ~ -24 | ~ 0 |
The interim report for Q3 2023/24 will be released as scheduled on 17 September 2024.
Frederikshavn, 16 September 2024
Roblon A/S
Jørgen Kjær Jacobsen Kim Müller Chairman CEO
____________________________________ __________________________________
For enquiries regarding this announcement, please contact the press and investor relations officer: Co-CEO/CFO Carsten Michno, tel. +45 9620 3300
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.